Swiss National Bank
DNTH icon

Swiss National Bank’s Dianthus Therapeutics DNTH Stock Holding History

Swiss National Bank’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.79M Buy
69,000
+37,600
+120% +$2.18M ﹤0.01% 1279
2025
Q4 		$1.29M Buy
+31,400
New +$1.22M ﹤0.01% 2062
2025
Q1 		– Sell
-14,400
Closed -$314K – 2413
2024
Q4 		$314K Sell
14,400
-2,900
-17% -$74.6K ﹤0.01% 2429
2024
Q3 		$474K Hold
17,300
– – ﹤0.01% 2442
2024
Q2 		$448K Buy
+17,300
New +$416K ﹤0.01% 2430

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Swiss National Bank's DNTH Position: Q1 2026 in Review

Swiss National Bank increased its Dianthus Therapeutics (DNTH) stake by 120% in Q1 2026, buying an estimated $2.18M and bringing the position to 69,000 shares worth $5.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

Swiss National Bank first reported a position in DNTH in Q2 2024 and has held it in 5 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Swiss National Bank held 69,000 shares of Dianthus Therapeutics worth $5.79M as of Q1 2026.
  • Swiss National Bank bought 37,600 Dianthus Therapeutics shares in Q1 2026, an estimated $2.18M.
  • Dianthus Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1279 holding.
  • Swiss National Bank first reported a position in Dianthus Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.